Peter Thiel-backed psychedelic start-up's shares pop in Wall Street debut
June 18, 2021 at 14:30 PM EDT
The German biotech's initial public offering was priced Thursday night at $15 per share, the high end of the expected range.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|